Cargando…

Three Cases of Previous Smokers with Rheumatoid Arthritis Who Did Not Respond to Tumor Necrosis Factor Inhibitors Were Treated Successfully with an Anti-Interleukin-6 Receptor Antibody

We report three cases of previous smokers who did not respond to TNF inhibitors but who responded successfully to an anti-interleukin-6 receptor antibody (tocilizumab (TCZ)). Case 1 is a 63-year-old woman whose smoking index was 200 and had been complaining of polyarthralgia since 1996. She started...

Descripción completa

Detalles Bibliográficos
Autor principal:	Iwata, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310487/ https://www.ncbi.nlm.nih.gov/pubmed/25648415 http://dx.doi.org/10.1155/2015/806725

Ejemplares similares

Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs
por: Wells, Alvin F., et al.
Publicado: (2019)

The Response by International Emergency Medical Teams Following the Beirut Harbor Explosion in 2020 – Who Were They, When Did They Arrive, What Did They Do, and Were They Needed?
por: Wolff, Emeli, et al.
Publicado: (2022)

Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture
por: Bainbridge, Chris, et al.
Publicado: (2012)

Characterization and Function of Tumor Necrosis Factor and Interleukin‐6–Induced Osteoclasts in Rheumatoid Arthritis
por: Yokota, Kazuhiro, et al.
Publicado: (2021)

Foreign Medical Teams in the Philippines after Typhoon Haiyan 2013 - Who Were They, When Did They Arrive and What Did They Do?
por: Brolin, Kim, et al.
Publicado: (2015)

Were they pushed or did they jump? : individual decision mechanisms in education /
por: Gambetta, Diego, 1952-
Publicado: (1987)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
por: Kaczyński, Tomasz, et al.
Publicado: (2019)

Interleukin 6 and Rheumatoid Arthritis
por: Yoshida, Yuji, et al.
Publicado: (2014)

Interleukin-6 in Rheumatoid Arthritis
por: Pandolfi, Franco, et al.
Publicado: (2020)

Biologic-free remission by orthopaedic surgery in non-responder to infliximab for rheumatoid arthritis
por: Kanbe, Katsuaki, et al.
Publicado: (2015)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Demographic differences between health care workers who did or did not respond to a safety and organizational culture survey
por: Listyowardojo, Tita A, et al.
Publicado: (2011)

Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: implications for autoimmunity in rheumatoid arthritis
por: Lugli, Elena B, et al.
Publicado: (2015)

Characteristics and outcomes of patients who did not respond to a national spine surgery registry
por: Kaur, Simran, et al.
Publicado: (2023)

Interleukin-7 deficiency in rheumatoid arthritis
por: Leonard, Warren J
Publicado: (2005)

The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
por: Schiff, M, et al.
Publicado: (2009)

Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis
por: Perry, M G, et al.
Publicado: (2009)

Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis.
por: Fröde, Tânia Silvia, et al.
Publicado: (2002)

Predictive factors for effective selection of Interleukin-6 inhibitor and tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis
por: Hayashi, Shinya, et al.
Publicado: (2020)

Who Did It?
por: Bainbridge, Laura
Publicado: (1887)

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register
por: Dixon, W G, et al.
Publicado: (2007)

“They Were Noble Automatons Who Knew Not What They Did:” Volition in Jaynes' The Origin of Consciousness in the Breakdown of the Bicameral Mind
por: Moore, James W.
Publicado: (2021)

WCN23-1161 LONG-TERM EVOLUTION OF KIDNEY FUNCTION OF COVID-19 SURVIVORS WHO WERE HOSPITALIZED AND DID OR DID NOT DEVELOP ACUTE KIDNEY INJURY
por: BECERRA GUTIERREZ, C.A., et al.
Publicado: (2023)

1055 Antibody Response to Intradermal and High Dose Influenza Vaccine in 2012-13 Among Adults Who Did and Did Not Respond to Standard Dose Vaccine in 2011-12
por: Sundaram, Maria, et al.
Publicado: (2014)

Patients with Rheumatoid Arthritis Were Associated with a Risk of Rotator Cuff Diseases
por: Wang, Wei-Te, et al.
Publicado: (2019)

Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis
por: Takasugi, Koji, et al.
Publicado: (2006)

Immunoregulatory role of interleukin 10 in rheumatoid arthritis
Publicado: (1994)

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
por: Hennigan, Stephanie, et al.
Publicado: (2008)

The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
por: Hashizume, Misato, et al.
Publicado: (2011)

Interleukin-17 in rheumatoid arthritis: Trials and tribulations
por: Taams, Leonie S.
Publicado: (2020)

Interleukin-9 Facilitates Osteoclastogenesis in Rheumatoid Arthritis
por: Kar, Santanu, et al.
Publicado: (2021)

Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis
por: Xin, Pan Lin, et al.
Publicado: (2021)

Influence of tumor necrosis factor α in rheumatoid arthritis
por: Kulp, Werner, et al.
Publicado: (2005)

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
por: Emery, P, et al.
Publicado: (2015)

Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib
por: Combe, Bernard, et al.
Publicado: (2019)

Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis
por: Ji, Hong, et al.
Publicado: (2002)

Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy
por: Suh, Young Sun, et al.
Publicado: (2014)

Efficacy and safety of abatacept in patients with rheumatoid arthritis with previous malignancy
por: Kunishita, Yosuke, et al.
Publicado: (2023)

Prevalence and Effects of Emphysema in Never-Smokers with Rheumatoid Arthritis Interstitial Lung Disease
por: Jacob, Joseph, et al.
Publicado: (2018)

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka, Toshio, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bludp8ced992a8oc1b3jutq42t